ESSA Pharma Inc.

EPIX · NASDAQ
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Assets
Cash & Equivalents$85,953$86,308$93,311$103,710
Short-Term Investments$23,667$27,564$27,242$23,051
Receivables$527$416$257$163
Inventory$0$0$0$0
Other Curr. Assets$355$879$1,295$636
Total Curr. Assets$110,502$115,167$122,105$127,560
Property Plant & Equip (Net)$0$248$272$295
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$257$257
Total NC Assets$0$248$529$552
Other Assets$0$0$0$0
Total Assets$110,502$115,415$122,634$128,112
Liabilities
Payables$971$864$1,836$2,404
Short-Term Debt$0$252$250$248
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$629$599$1,602$649
Total Curr. Liab.$1,600$1,715$3,687$3,301
LT Debt$0$154$180$205
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$154$180$205
Other Liabilities$0$0$0$0
Cap. Leases$0$280$305$329
Total Liabilities$1,600$1,869$3,867$3,506
Equity
Pref Stock$0$0$0$0
Common Stock$279,862$279,862$279,862$279,862
Retained Earnings-$226,914-$222,911-$216,536-$208,004
AOCI-$2,097-$2,090-$2,072-$2,063
Other Equity$58,051$58,685$57,513$54,811
Total Equity$108,902$113,547$118,767$124,606
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$110,502$115,415$122,634$128,112
Net Debt-$85,953-$85,902-$92,881-$103,256